Skip to main content

Table 5 Summary of postoperative relapses excluding patients who received PAC (n = 34)

From: Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study

Location

Treatment group

NAC (n = 18)

NACRT (n = 16)

Overall relapse (present), n (%)

1 (5%)

5 (31%)

Local relapse (present), n (%)

1 (5%)

2 (13%)

Distal relapse (pulmonary and liver), n (%)

0

3 (19%)